Trials / Sponsors / BlueSky Immunotherapies GmbH
BlueSky Immunotherapies GmbH
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer Oropharyngeal Squamous Cell Carcinoma (SCC) | Phase 1 | 2024-08-23 |
| Recruiting | Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women HPV Infection, HPV-Related Cervical Carcinoma | Phase 1 | 2023-09-12 |
| Completed | BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects Safety Issues, HPV Infection | — | 2021-04-09 |
| Completed | Study of FluBHPVE6E7 in HPV-16 Infected Women HPV Infection | Phase 1 | 2020-12-09 |